Acceleron Pharma Inc XLRN
Morningstar Growth Grade = A
Projected Annual Growth = 15.7%
June 25, 2021 price = $124.44
Company Profile
Business Description
Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. Acceleron generates its revenue through collaboration, licensing, and research arrangements with collaboration partners for the development and commercialization of therapeutic candidates. The company sometimes uses contract research organizations and research institutions outside the United States.
Contact128 Sidney Street
Cambridge, MA, 02139
Cambridge, MA, 02139
T +1 617 649-9200
SectorHealthcare
IndustryBiotechnology
Most Recent EarningsMar 31, 2021
Fiscal Year EndDec 31, 2021
Stock TypeSpeculative Growth
Employees312
No comments:
Post a Comment